Literature DB >> 19500466

Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease.

Berthold Amann1, Claas Luedemann, Richard Ratei, J André Schmidt-Lucke.   

Abstract

Bone marrow cell transplantation has been shown to induce angiogenesis and thus improve ischemic artery disease. This study evaluates the effects of intramuscular bone marrow cell transplantation in patients with limb-threatening critical limb ischemia with a very high risk for major amputation. After failed or impossible operative and/or interventional revascularization and after unsuccessful maximum conservative therapy, 51 patients with impending major amputation due to severe critical limb ischemia had autologous bone marrow cells (BMC) transplanted into the ischemic leg. Patients 1-12 received Ficoll-isolated bone marrow mononuclear cells (total cell number 1.1 +/- 1.1 x 10(9)), patients 13-51 received point of care isolated bone marrow total nucleated cells (3.0 +/- 1.7 x 10(9)). Limb salvage was 59% at 6 months and 53% at last follow-up (mean 411 +/- 261 days, range 175-1186). Perfusion measured with ankle-brachial index (ABI) and transcutaneous oxygen tension (tcpO(2)) at baseline and after 6 months increased in patients with consecutive limb salvage (ABI 0.33 +/- 0.18 to 0.46 +/- 0.15, tcpO(2) 12 +/- 12 to 25 +/- 15 mmHg) and did not change in patients eventually undergoing major amputation. No difference in clinical outcome between the isolation methods were seen. Clinically most important, patients with limb salvage improved from a mean Rutherford category of 4.9 at baseline to 3.3 at 6 months (p = 0.0001). Analgesics consumption was reduced by 62%. Total walking distance improved in nonamputees from zero to 40 m. Three severe periprocedural adverse events resolved without sequelae, and no unexpected long-term adverse events occurred. In no-option patients with end-stage critical limb ischemia due to peripheral artery disease, bone marrow cell transplantation is a safe procedure that can improve leg perfusion sufficiently to reduce major amputations and permit durable limb salvage.

Entities:  

Mesh:

Year:  2009        PMID: 19500466     DOI: 10.3727/096368909788534942

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  62 in total

1.  Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.

Authors:  Michael P Murphy; Jeffrey H Lawson; Brian M Rapp; Michael C Dalsing; Janet Klein; Michael G Wilson; Gary D Hutchins; Keith L March
Journal:  J Vasc Surg       Date:  2011-04-22       Impact factor: 4.268

2.  [Cutaneous wound healing. Therapeutic interventions].

Authors:  J Heinlin; S Schreml; P Babilas; M Landthaler; S Karrer
Journal:  Hautarzt       Date:  2010-07       Impact factor: 0.751

3.  A Prospective, Nonrandomized, no Placebo-Controlled, Phase I/II Clinical Trial Assessing the Safety and Efficacy of Intramuscular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Patients With Severe Buerger's Disease.

Authors:  Jeong Chan Ra; Euicheol C Jeong; Sung Keun Kang; Seog Ju Lee; Kyoung Ho Choi
Journal:  Cell Med       Date:  2016-10-03

4.  Mesenchymal stem cell treatment attenuates liver and lung inflammation after ethanol intoxication and burn injury.

Authors:  Brenda J Curtis; Jill A Shults; Devin M Boe; Luis Ramirez; Elizabeth J Kovacs
Journal:  Alcohol       Date:  2018-09-11       Impact factor: 2.405

Review 5.  [Cell therapy in bone-healing disorders].

Authors:  M Jäger; P Hernigou; C Zilkens; M Herten; J Fischer; R Krauspe
Journal:  Orthopade       Date:  2010-04       Impact factor: 1.087

Review 6.  Concise review: therapeutic potential of adipose tissue-derived angiogenic cells.

Authors:  Krisztina Szöke; Jan E Brinchmann
Journal:  Stem Cells Transl Med       Date:  2012-09-07       Impact factor: 6.940

7.  Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer.

Authors:  V Procházka; J Gumulec; F Jalůvka; D Salounová; T Jonszta; D Czerný; J Krajča; R Urbanec; P Klement; J Martinek; G L Klement
Journal:  Cell Transplant       Date:  2010-06-07       Impact factor: 4.064

Review 8.  Intraoperative stem cell therapy.

Authors:  Mónica Beato Coelho; Joaquim M S Cabral; Jeffrey M Karp
Journal:  Annu Rev Biomed Eng       Date:  2012       Impact factor: 9.590

9.  Management of infrapopliteal peripheral arterial occlusive disease.

Authors:  Warren J Gasper; Sara J Runge; Christopher D Owens
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-04

Review 10.  Theory, instrumentation, and applications of electron paramagnetic resonance oximetry.

Authors:  Rizwan Ahmad; Periannan Kuppusamy
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.